Teachers Retirement System of The State of Kentucky Reduces Stake in DaVita Inc. (NYSE:DVA)

Teachers Retirement System of The State of Kentucky trimmed its position in shares of DaVita Inc. (NYSE:DVA) by 17.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,723 shares of the company’s stock after selling 803 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in DaVita were worth $610,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of DVA. Blue Trust Inc. boosted its position in shares of DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after buying an additional 78 shares in the last quarter. Atria Wealth Solutions Inc. lifted its holdings in shares of DaVita by 26.7% in the second quarter. Atria Wealth Solutions Inc. now owns 6,068 shares of the company’s stock valued at $841,000 after purchasing an additional 1,279 shares in the last quarter. Family Firm Inc. acquired a new stake in shares of DaVita in the second quarter valued at approximately $43,000. AlphaCentric Advisors LLC increased its stake in shares of DaVita by 75.2% during the 2nd quarter. AlphaCentric Advisors LLC now owns 1,451 shares of the company’s stock worth $201,000 after purchasing an additional 623 shares in the last quarter. Finally, Kintegral Advisory LLC raised its position in shares of DaVita by 63.9% during the 2nd quarter. Kintegral Advisory LLC now owns 7,961 shares of the company’s stock worth $1,103,000 after purchasing an additional 3,105 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Truist Financial increased their target price on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. Barclays increased their price objective on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, DaVita currently has an average rating of “Hold” and an average target price of $161.80.

DaVita Price Performance

Shares of NYSE:DVA opened at $146.76 on Thursday. The company has a market cap of $12.03 billion, a P/E ratio of 15.83, a P/E/G ratio of 0.86 and a beta of 0.90. The business has a fifty day simple moving average of $157.42 and a 200-day simple moving average of $150.86. DaVita Inc. has a 52 week low of $103.40 and a 52 week high of $169.51. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the company earned $2.85 EPS. The company’s revenue was up 4.6% compared to the same quarter last year. Equities research analysts forecast that DaVita Inc. will post 9.71 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.